Clinical trial

TILs Plus Third-Generation EGFR-TKI Therapy for TKI-Resistant NSCLC

NCT07498595

StatusNOT_YET_RECRUITING

Study typeINTERVENTIONAL

Start date2026-03-31

PhaseEARLY_PHASE1

Study timeline

Study start (estimated)2026-03-31Date precision: day

Registry last updated2026-03-27

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

EGFR-TKI-resistant Non-Small Cell Lung Cancerunresolved

Interventions

TILs infusionDRUG

Sponsors & collaborators

Tianjin Medical University General Hospitallead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07498595 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.